Friday Nov 22
Stifel Nicolaus Reiterates "Buy" Rating for HealthSouth Corp.
's stock had its "buy" rating reaffirmed by equities researchers at Stifel Nicolaus in a research report issued on Friday, Stock Ratings Network.com reports.
HealthSouth Corp. PT Raised to $40.00 at Susquehanna
The firm currently has a "positive" rating on the stock. Susquehanna's price target would indicate a potential upside of 16.75% from the stock's previous close.
HealthSouth enters into privately negotiated exchange agreements
HealthSouth Corporation today announced that the Company entered into separate, privately negotiated exchange agreements under which it will issue $320 million in aggregate principal amount of new 2.0% Convertible Senior Subordinated Notes due 2043 in exchange for 257,110 shares of the Company's outstanding 6.5% Series A Convertible Perpetual ... (more)
Scrushy accepts responsibility for multibillion-dollar HealthSouth fraud
Richard Scrushy is accepting blame for the multibillion-dollar fraud at HealthSouth Corp. though the crestfallen former CEO still denies he knew it was taking place.